Spinal muscular atrophy - the dawning of a new era.
Michelle A Farrar, Matthew C Kiernan
Author Information
- Michelle A Farrar: Discipline of Paediatrics, School of Women's and Children's Health, UNSW Medicine, UNSW Sydney, Sydney, New South Wales, Australia. m.farrar@unsw.edu.au. ORCID
- Matthew C Kiernan: Brain & Mind Centre and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. ORCID
No abstract text available.
- Coovert, D. D. et al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205–1214 (1997).
[PMID: 9259265]
- Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723–1732 (2017).
[PMID: 29091570]
- Canadian Agency for Drugs and Technologies in Health. Nusinersen. CADTH, https://www.cadth.ca/nusinersen (2017).
- World Health Organization. Improving the transparency of markets for medicines, vaccines, and other health products. WHO, https://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_ACONF2Rev1-en.pdf (2019).
- Powell, T. & O’Donnell, M. NICE appraisals of rare disease. House of Commons Library, https://researchbriefings.files.parliament.uk/documents/CDP-2019-0022/CDP-2019-0022.pdf (2019).
- De Vivo, D. C. et al. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study. Neuromuscul. Disord. 29, 842–856 (2019).
[PMID: 31704158]
- Kariyawasam, D. S. T., Russell, J. S., Wiley, V., Alexander, I. E. & Farrar, M. A. The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genet. Med. 22, 557–565 (2020).
[PMID: 31607747]
- Glascock, J. et al. Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2. J Neuromuscul. Dis. 7, 97–100 (2020).
[PMID: 32007960]
- Beauchamp, K. A., Johansen Taber, K. A. & Muzzey, D. Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen. Genet. Med. 21, 1948–1957 (2019).
[PMID: 30760891]
- Kariyawasam, D., Alexander, I. E., Kurian, M. & Farrar, M. A. Great expectations: virus-mediated gene therapy in neurological disorders. J. Neurol. Neurosurg. Psychiatry 91, 849–860 (2020).
[PMID: 32503884]
Humans
Muscular Atrophy, Spinal
Spinal Muscular Atrophies of Childhood
